Stansberry Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.2M Sell
59,659
-22,679
-28% -$6.27M 1.21% 27
2026
Q1
$24.3M Buy
82,338
+337
+0.4% +$100K 2.5% 4
2025
Q4
$22.4M Buy
82,001
+1,439
+2% +$391K 2.27% 10
2025
Q3
$21.8M Buy
80,562
+978
+1% +$266K 2.28% 9
2025
Q2
$21.9M Buy
79,584
+33,518
+73% +$9.11M 2.4% 8
2025
Q1
$12.2M Buy
46,066
+4,459
+11% +$1.1M 1.47% 21
2024
Q4
$9.66M Sell
41,607
-38
-0.1% -$8.74K 1.25% 30
2024
Q3
$9.19M Buy
41,645
+338
+0.8% +$69.9K 1.15% 32
2024
Q2
$8.12M Buy
41,307
+4,319
+12% +$892K 1.07% 35
2024
Q1
$7.96M Buy
36,988
+2,438
+7% +$512K 1.07% 36
2023
Q4
$7.28M Buy
34,550
+3,611
+12% +$770K 1.21% 32
2023
Q3
$6.19M Buy
30,939
+2,988
+11% +$594K 1.08% 32
2023
Q2
$5.18M Buy
27,951
+7,334
+36% +$1.36M 0.95% 37
2023
Q1
$3.95M Buy
+20,617
New +$3.73M 0.77% 40

Other funds holding CME

Stansberry Asset Management's CME Position: Q2 2026 in Review

Stansberry Asset Management reduced its CME Group (CME) stake by 28% in Q2 2026, selling an estimated $6.27M and leaving 59,659 shares worth $13.2M. The position accounts for 1.21% of the portfolio, ranked #27.

Stansberry Asset Management first reported a position in CME in Q1 2023 and has held it in 14 quarters since. The position peaked at $24.3M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Stansberry Asset Management held 59,659 shares of CME Group worth $13.2M as of Q2 2026.
  • Stansberry Asset Management sold 22,679 CME Group shares in Q2 2026, an estimated $6.27M.
  • CME Group made up 1.21% of Stansberry Asset Management's portfolio in Q2 2026, its #27 holding.
  • Stansberry Asset Management first reported a position in CME Group in Q1 2023 and has held it in 14 quarters since.
  • Stansberry Asset Management's CME Group position peaked at $24.3M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Stansberry Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.